SAMANTHA BONIN: Open Payments
NPI 1053056663 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,137 in 50 payments from 9 companies in 2025. Trend: 2023 $1,009 · 2024 $1,345 · 2025 $2,137
Food & beverage: $1,771Travel & lodging: $365
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 24 | $984 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 11 | $181 |
| HEARTFLOW, INC. | 2 | $168 |
| SCPHARMACEUTICALS INC. | 5 | $163 |
| Novo Nordisk Inc | 2 | $146 |
| Medtronic, Inc. | 1 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 2 | $122 |
| E.R. Squibb & Sons, L.L.C. | 2 | $105 |
Products named: CARDIOMEMS, LifeVest, FFRct, FUROSCIX, Wegovy, COREVALVE EVOLUT R, JARDIANCE, FARXIGA.
Industry payments across IA — which companies pay providers there.
